Cardiometabolic Effects of Pecan Snacking in Prediabetes
ConditionPrediabetes
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age25-65
SponsorPenn State University
About this trial
The purpose of this study is to investigate the effects of replacing snacks higher in saturated fats and added sugars with pecans on blood sugar control, heart health and diet quality in individuals with prediabetes. Participants will be randomized into one of two groups. Group 1 will consume 1.5 oz of pecans per day in place of normally consumed snacks higher in saturated fat and added sugars for 16 weeks. Group 2 will be asked to continue consuming their current diet for 16 weeks. Measures will be taken to evaluate blood sugar, heart health and dietary intake at the beginning and 16 weeks later.
Eligibility criteria
Qualifiers
Age 25-65 years
Prediabetes assessed by an HbA1c of 5.7-6.4% at screening
BMI 25-40 kg/m2 at screening
Low habitual nut consumption (<3.5 oz-eq/week) assessed at the telephone screening
Disqualifiers
LDL-C ≥190 mg/dL at screening
Hemoglobin <13.2 g/dL at screening
Fasting triglycerides >350 mg/dL at screening
≥10% change in body weight within the 6 months prior to enrollment
Trial design
Treatments tested in this trial
- Pecan snacking
- Usual diet
Treatment groups
147 Participants
are divided into 2 treatment groupsLocations
1The Pennsylvania State University16802, University ParkPennsylvania, United States
Sponsors and collaborators
Penn State University
Lead sponsor
American Pecan Promotion Board
Collaborator
Source ClinicalTrials.gov